BioUK Awards 2026 celebrate innovation in UK life sciences
BioUK has announced the winners of the 18th annual BioUK Awards following a ceremony hosted at the Royal Lancaster Hotel, London.
The biopharma and biotech winners of the 2026 BioUK Awards included:
- The Best Start-Up Biotech Company Award, sponsored by Milton Park, was awarded to U-Ploid Biotechnologies, who are developing a first-in-class therapeutic targeting age-related infertility.
- The Best Emerging Biotech Company Award, sponsored by Thermo Fisher Scientific, went to Mursla Bio, a leader in extracellular vesicle science.
- The Most Impactful Deal Award, sponsored by Mills & Reeve, was presented to Bicycle Therapeutics, who through agreements with the NDA, UKNNL, and SpectronRx, have created the world’s first end-to-end 212Pb radiopharmaceutical ecosystem.
- The Most Impactful CRO Award, sponsored by Gallagher, was presented to Qureight, an end-to-end imaging CRO.
- The Best Established Biotech Company Award, sponsored by Precision for Medicine, went to Oxford-based Sitryx Therapeutics who are pioneering immunometabolism for patients with chronic autoimmune and inflammatory disease.
- The Emerging Life Sciences Entrepreneur of the Year Award, sponsored by Informa, went to Stephanie Annett, Senior lecturer and Principle Investigator at RCSI University of Medicine and Health Sciences and interim CEO of ImuPhile.
- The Special Recognition Award was presented to Professor Matthew Wood for his work to advance the global fight against rare diseases.
Stuart Rose, CEO, commented: “The BioUK Awards bring together the very best of the UK life sciences, and this year’s finalists truly reflect the innovation, determination and scientific rigour that make our sector a leading voice on the global stage. Thank you to everyone who has supported this year’s programme, allowing us to recognise and celebrate the amazing science that is helping to bring real benefit to patients across the world.”
